Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuro Oncol ; 12(8): 799-803, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20200025

ABSTRACT

Hepatocyte growth factor (HGF) and its receptor c-Met have been known as key determinants of growth and angiogenesis in some brain tumors like gliomas, meningiomas, and schwannomas. But little is known about their expression in pituitary adenomas. In this study, the expression of HGF and c-Met in pituitary adenomas of different histology types was investigated by immunohistochemistry, and correlative analysis of their expression with microvessel density (MVD), Ki-67 expression, and other clinicopathologic factors was made. The results showed that the expression of HGF and c-Met exists in 98% (64 of 65) and 92% (60 of 65) pituitary adenomas, respectively, and co-expression of them existed in 91% (59 of 65) adenomas. HGF had significant correlation with MVD (Spearman's correlation coefficient, r = .31, P = .01) and Ki-67 (r = .32, P = .01). c-Met had significant correlation with MVD (r = .30, P = .02) and Ki-67 (r = .38, P = .00). HGF and c-Met expression had no significant correlation with age or extrasellar extension. There were no significant differences in HGF and c-Met expression between pituitary adenomas of different histology types. The results indicate that HGF and c-Met are widely expressed in pituitary adenomas, and their expression correlates with MVD and Ki-67 expression.


Subject(s)
Adenoma/metabolism , Adenoma/pathology , Hepatocyte Growth Factor/biosynthesis , Pituitary Neoplasms/metabolism , Pituitary Neoplasms/pathology , Proto-Oncogene Proteins c-met/biosynthesis , Adult , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Ki-67 Antigen/metabolism , Middle Aged , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...